Cargando…

Pneumocystis pneumonia in South African children diagnosed by molecular methods

BACKGROUND: Pneumocystis pneumonia (PCP) is an important cause of hospitalization and mortality in HIV-infected children. However, the incidence of PCP has been underestimated due to poor sensitivity of diagnostic tests. The use of polymerase chain reaction (PCR) for pneumocystis has enabled more re...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrow, Brenda M, Samuel, Catherine M, Zampoli, Marco, Whitelaw, Andrew, Zar, Heather J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892044/
https://www.ncbi.nlm.nih.gov/pubmed/24410938
http://dx.doi.org/10.1186/1756-0500-7-26
_version_ 1782299452217753600
author Morrow, Brenda M
Samuel, Catherine M
Zampoli, Marco
Whitelaw, Andrew
Zar, Heather J
author_facet Morrow, Brenda M
Samuel, Catherine M
Zampoli, Marco
Whitelaw, Andrew
Zar, Heather J
author_sort Morrow, Brenda M
collection PubMed
description BACKGROUND: Pneumocystis pneumonia (PCP) is an important cause of hospitalization and mortality in HIV-infected children. However, the incidence of PCP has been underestimated due to poor sensitivity of diagnostic tests. The use of polymerase chain reaction (PCR) for pneumocystis has enabled more reliable diagnosis. This study describes the incidence, clinical features and outcome of PCP in South African children diagnosed using PCR. METHODS: A prospective study of children hospitalised in South Africa with suspected PCP was done from November 2006 to August 2008. Clinical, laboratory and radiological information were collected. Lower respiratory tract specimens were obtained for PCP immunofluorescence (IF), real- time PCR for pneumocystis, bacterial and mycobacterial culture. Nasopharyngeal aspirates were taken for immunofluorescence (IF), real-time PCR for pneumocystis and PCR for respiratory viruses. A blood specimen for bacterial culture and for cytomegalovirus PCR was taken. Children were followed for the duration of their hospitalisation and the outcome was recorded. RESULTS: 202 children [median (interquartile range, IQR) age 3.2 (2.1– 4.6) months] were enrolled; 124 (61.4%) were HIV infected. PCP was identified in 109 (54%) children using PCR, compared to 43 (21%) using IF and Grocott staining (p < 0.0001). Most PCP cases (88, 81%) occurred in HIV-infected children. All 21 cases (19%) occurring in HIV- negative children had another risk factor for PCP. On logistic regression, predictive factors for PCP were HIV infection, lack of fever, high respiratory rate and low oxygen saturation whilst cotrimoxazole prophylaxis was protective (OR 0.24; 95% CI 0.1 to 0.5; p < 0.002). The case fatality of children with PCP was higher than those without PCP (32.1% versus 17.2%; relative risk 1.87; 95% confidence interval (CI) 1.11 – 3.15). Amongst HIV-infected children, a CD4 less than 15% was the only independent predictor of mortality. CONCLUSIONS: The diagnostic yield for PCP is more than 2.5 times higher on PCR than other detection methods. PCP is a very common cause of severe hypoxic pneumonia and is associated with high mortality in HIV-infected African infants.
format Online
Article
Text
id pubmed-3892044
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38920442014-01-15 Pneumocystis pneumonia in South African children diagnosed by molecular methods Morrow, Brenda M Samuel, Catherine M Zampoli, Marco Whitelaw, Andrew Zar, Heather J BMC Res Notes Research Article BACKGROUND: Pneumocystis pneumonia (PCP) is an important cause of hospitalization and mortality in HIV-infected children. However, the incidence of PCP has been underestimated due to poor sensitivity of diagnostic tests. The use of polymerase chain reaction (PCR) for pneumocystis has enabled more reliable diagnosis. This study describes the incidence, clinical features and outcome of PCP in South African children diagnosed using PCR. METHODS: A prospective study of children hospitalised in South Africa with suspected PCP was done from November 2006 to August 2008. Clinical, laboratory and radiological information were collected. Lower respiratory tract specimens were obtained for PCP immunofluorescence (IF), real- time PCR for pneumocystis, bacterial and mycobacterial culture. Nasopharyngeal aspirates were taken for immunofluorescence (IF), real-time PCR for pneumocystis and PCR for respiratory viruses. A blood specimen for bacterial culture and for cytomegalovirus PCR was taken. Children were followed for the duration of their hospitalisation and the outcome was recorded. RESULTS: 202 children [median (interquartile range, IQR) age 3.2 (2.1– 4.6) months] were enrolled; 124 (61.4%) were HIV infected. PCP was identified in 109 (54%) children using PCR, compared to 43 (21%) using IF and Grocott staining (p < 0.0001). Most PCP cases (88, 81%) occurred in HIV-infected children. All 21 cases (19%) occurring in HIV- negative children had another risk factor for PCP. On logistic regression, predictive factors for PCP were HIV infection, lack of fever, high respiratory rate and low oxygen saturation whilst cotrimoxazole prophylaxis was protective (OR 0.24; 95% CI 0.1 to 0.5; p < 0.002). The case fatality of children with PCP was higher than those without PCP (32.1% versus 17.2%; relative risk 1.87; 95% confidence interval (CI) 1.11 – 3.15). Amongst HIV-infected children, a CD4 less than 15% was the only independent predictor of mortality. CONCLUSIONS: The diagnostic yield for PCP is more than 2.5 times higher on PCR than other detection methods. PCP is a very common cause of severe hypoxic pneumonia and is associated with high mortality in HIV-infected African infants. BioMed Central 2014-01-10 /pmc/articles/PMC3892044/ /pubmed/24410938 http://dx.doi.org/10.1186/1756-0500-7-26 Text en Copyright © 2014 Morrow et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Morrow, Brenda M
Samuel, Catherine M
Zampoli, Marco
Whitelaw, Andrew
Zar, Heather J
Pneumocystis pneumonia in South African children diagnosed by molecular methods
title Pneumocystis pneumonia in South African children diagnosed by molecular methods
title_full Pneumocystis pneumonia in South African children diagnosed by molecular methods
title_fullStr Pneumocystis pneumonia in South African children diagnosed by molecular methods
title_full_unstemmed Pneumocystis pneumonia in South African children diagnosed by molecular methods
title_short Pneumocystis pneumonia in South African children diagnosed by molecular methods
title_sort pneumocystis pneumonia in south african children diagnosed by molecular methods
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892044/
https://www.ncbi.nlm.nih.gov/pubmed/24410938
http://dx.doi.org/10.1186/1756-0500-7-26
work_keys_str_mv AT morrowbrendam pneumocystispneumoniainsouthafricanchildrendiagnosedbymolecularmethods
AT samuelcatherinem pneumocystispneumoniainsouthafricanchildrendiagnosedbymolecularmethods
AT zampolimarco pneumocystispneumoniainsouthafricanchildrendiagnosedbymolecularmethods
AT whitelawandrew pneumocystispneumoniainsouthafricanchildrendiagnosedbymolecularmethods
AT zarheatherj pneumocystispneumoniainsouthafricanchildrendiagnosedbymolecularmethods